In conclusion, BCL2 expression evaluated by AQUA scoring system incorporating both intensity and proportion of BCL2 was an independent prognostic factor in patients with DLBCL treated with R-CHOP. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.